Valeria Sorrenti

Prof. Valeria Sorrenti

Department of Drug and Health Sciences
orcid

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
VSValeria Sorrenti
Valeria Sorrenti
IBIlaria Burò
Ilaria Burò
VCValeria Consoli
Valeria Consoli
Luca VanellaLuca Vanella
Luca Vanella
Bioactive compounds, including terpenoids, polyphenols, alkaloids and other nitrogen-containing constituents, exert various beneficial effects arising from their antioxidant and anti-inflammatory properties. These compounds can be found in vegetables, fruits, grains, spices and their derived foods and beverages such as tea, olive oil, fruit juices, wine, chocolate and beer. Agricultural production and the food supply chain are major sources of food wastes, which can become resources, as they are rich in bioactive compounds. The aim of this review is to highlight recent articles demonstrating the numerous potential uses of products and by-products of the agro-food supply chain, which can have various applications.

16 April 2021 in Biomolecules
Verified
Journal Article
Open access
PDF file
VCValeria Consoli
Valeria Consoli
VSValeria Sorrenti
Valeria Sorrenti
SGSalvo Grosso
Salvo Grosso
Luca VanellaLuca Vanella
Luca Vanella
Heme-oxygenase is the enzyme responsible for degradation of endogenous iron protoporphyirin heme; it catalyzes the reaction’s rate-limiting step, resulting in the release of carbon monoxide (CO), ferrous ions, and biliverdin (BV), which is successively reduced in bilirubin (BR) by biliverdin reductase. Several studies have drawn attention to the controversial role of HO-1, the enzyme inducible isoform, pointing out its implications in cancer and other diseases development, but also underlining the importance of its antioxidant activity. The contribution of HO-1 in redox homeostasis leads to a relevant decrease in cells oxidative damage, which can be reconducted to its cytoprotective effects explicated alongside other endogenous mechanisms involving genes like TIGAR (TP53-induced glycolysis and apoptosis regulator), but also to the therapeutic functions of heme main transformation products, especially carbon monoxide (CO), which has been shown to be effective on GSH levels implementation sustaining body’s antioxidant response to oxidative stress. The aim of this review was to collect most of the knowledge on HO-1 from literature, analyzing different perspectives to try and put forward a hypothesis on revealing yet unknown HO-1-involved pathways that could be useful to promote development of new therapeutical strategies, and lay the foundation for further investigation to fully understand this important antioxidant system.

1 April 2000 in Cell Biology and Toxicology
Verified
Journal Article
Closed access
PDF file
ARAlessandra Russo
Alessandra Russo
Rosaria AcquavivaRosaria Acquaviva
Rosaria Acquaviva
ACAgata Campisi
Agata Campisi
VSValeria Sorrenti
Valeria Sorrenti
CGClaudia Di Giacomo
Claudia Di Giacomo
AVA. Vanella
A. Vanella

1 February 2002 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
LSL. Saleron
L. Saleron
VSValeria Sorrenti
Valeria Sorrenti
CGClaudia Di Giacomo
Claudia Di Giacomo
GRG. Romeo
G. Romeo
MSM. A. Siracusa
M. A. Siracusa
Nitric oxide (NO), a molecular messenger synthesized by nitric oxide synthase (NOS) from L-arginine and molecular oxygen, is involved in a number of physiological and pathological processes in mammalians. Three structurally distinct isoforms of NOS have been identified: neuronal (nNOS), endothelial (eNOS) and inducible (iNOS). Although NO mediates several physiological functions, overproduction of NO by nNOS has been reported in a number of clinical disorders including acute (stroke) and chronic (schizophrenia, Alzheimers, Parkinsons and AIDS dementia) neurodegenerative diseases, convulsions and pain overproduction of NO by iNOS has been implicated in various pathological processes including septic shock, tissue damage following inflammation and rheumatoid arthritis. On the contrary, NO produced by eNOS has only physiological roles such as maintaining physiological vascular tone. Accordingly, selective inhibition of nNOS or iNOS vs eNOS may provide a novel therapeutic approach to various diseases in addition selective inhibitors may represent useful tools for investigating other biological functions of NO. For these reasons, after the identification of N-methyl-L-arginine (L-NMA) as the first inhibitor of NO biosynthesis, design of selective NOS inhibitors has received much attention. In this article the recent developments of new molecules endowed with inhibitory properties against the various isoforms of NOS are reviewed. Major focus is placed on structure-activity-selectivity relationships especially concerning compounds belonging to the non-aminoacid-based inhibitors.

11 October 2013 in Toxins
Verified
Journal Article
Open access
PDF file
VSValeria Sorrenti
Valeria Sorrenti
CGClaudia Di Giacomo
Claudia Di Giacomo
Rosaria AcquavivaRosaria Acquaviva
Rosaria Acquaviva
Ignazio BarbagalloIgnazio Barbagallo
Ignazio Barbagallo
MBMatteo Bognanno
Matteo Bognanno
Fabio GalvanoFabio Galvano
Fabio Galvano
Ochratoxin A (OTA) is a mycotoxin involved in the development of different types of cancers in rats, mice and humans. A growing number of in vitro and in vivo studies has been collected and has described evidence compatible with a role for oxidative stress in OTA toxicity and carcinogenicity. Because the contribution of the oxidative stress response in the development of cancers is well established, a role in OTA carcinogenicity is plausible. Several studies have been performed to try to counteract the adverse effects of oxygen radicals generated under OTA-exposure. A number of molecules with various antioxidant properties were tested, using in vivo or in vitro models. Protection against OTA-induced DNA damage, lipid peroxidation, as well as cytotoxicity were observed, further confirming the link between OTA toxicity and oxidative damage. These studies demonstrated that antioxidants are able to counteract the deleterious effects of chronic consumption or exposure to OTA and confirmed the potential effectiveness of dietary strategies to counteract OTA toxicity.

1 April 2000 in Cell Biology and Toxicology
Verified
Journal Article
Closed access
PDF file
AVA. Vanella
A. Vanella
ARAlessandra Russo
Alessandra Russo
Rosaria AcquavivaRosaria Acquaviva
Rosaria Acquaviva
ACAgata Campisi
Agata Campisi
CGClaudia Di Giacomo
Claudia Di Giacomo
MBM.L. Barcellona
M.L. Barcellona